HCP Campaign Communication with AI Support

How a leading international pharma company produces regulation-compliant HCP assets across all digital formats dramatically faster and more cost-effectively

Learn how a leading international pharma company revolutionized the production of regulation-compliant HCP assets with Caidera.

At a Glance

✓Asset creation time: over 90% time savings
✓Cost reduction vs. agency: approx. 80%
✓Time-to-market: under 1 day vs. 4–8 weeks

About Pharma

The company is a leading international pharmaceutical company with a broad product portfolio across multiple therapeutic areas. The HCP marketing team manages digital communication with specialist physicians across multiple international markets via Approved Emails, newsletters, eDetailers, digital banners, and social content.

The Challenge

The HCP marketing team faced central challenges in the scalable production of regulation-compliant digital assets.

High Multi-Format Demand

Campaigns require simultaneous Approved Emails, newsletters, eDetailers, banners, and social posts – for multiple markets and specialist groups. Manual agency production does not scale.

High Production Costs

Individual HCP assets cost an average of €8,000–15,000 through specialized agencies – including medical copywriting, design, and compliance coordination.

Slow MLR Process

Every asset goes through Brand, Medical Affairs, and Legal. Typical turnaround times: 4–8 weeks. Even the smallest content changes trigger new review rounds.

The Solution

Caidera was introduced as a specialized AI platform for regulated healthcare marketing – from the initial briefing idea to approval-ready versions in all formats. • Product-specific knowledge base with brand guidelines and regulatory requirements • Template library for all HCP formats: Approved Email, Newsletter, eDetailer, Banner, Social Post • Automatic market and language adaptation • Direct integration into existing MLR workflows • GDPR-compliant, certified infrastructure

Results

90%+Time Saved

Asset Creation

~80%Cost Reduction

Cost vs. Agency

<1 Tagvs. 4–8 weeks

Time-to-Market

The automation relieved the team from repetitive format production and created capacity for strategic work. The final MLR approval remains unchanged – however, approval-ready versions are available much earlier.

“With Caidera, we produce regulation-compliant HCP assets in a fraction of the time and cost. The platform understands our compliance requirements and delivers approval-ready results.”

HCP Marketing, Leading Pharma Company

Conclusion & Outlook

The pilot project demonstrates that AI-powered automation works reliably even in highly regulated marketing environments – without compromising compliance or medical quality. The company plans to roll out Caidera as a standard production platform for additional therapeutic areas and markets.